
    
      This is a prospective, open-label, multicentric, 2 groups study to assess the safety and
      performance of the Genio™ system in adult obstructive sleep apnoea (OSA) patients with and
      without complete concentric collapse of the soft palate. Participants will be consented,
      enrolled and eligibility criteria checked. If the participant is eligible, participant will
      proceed with the Genio™ IS implantation. Six (6) weeks after implantation, the implant will
      be activated and study visits will be scheduled at Week 7, Month 2, Month 3, Month 4, Month 5
      and Month 6.
    
  